Clinical trials for Cancer in United States

Identification of Biomarkers for Patients with Vascular Anomalies

Study ID: NCT03001180

Sponsor

Children's Hospital Medical Center, Cincinnati

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

Study ID: NCT06222580

Sponsor

A borate

Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC

Study ID: NCT05645380

Sponsor

University of Kansas Medical Center

A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

Study ID: NCT06130280

Sponsor

Memorial Sloan Kettering Cancer Center

A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Recurrent/Metastatic Head and Neck Cancer

Study ID: NCT06385080

Sponsor

Janssen Research & Development, LLC

Cabozantinib in Combination with Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

Study ID: NCT04878029

Sponsor

Emory University

Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer Tissue

Study ID: NCT02379429

Sponsor

National Cancer Institute (NCI)

Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

Study ID: NCT03589729

Sponsor

M.D. Anderson Cancer Center

Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes

Study ID: NCT03830229

Sponsor

National Cancer Institute (NCI)

Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC)

Study ID: NCT06085729

Sponsor

M.D. Anderson Cancer Center